ABOUT THE SERVICE
NavDx® is a liquid biopsy test that uses proprietary technology to detect tumor-tissue-modified DNA (TTMV) in the blood, enabling ultrasensitive surveillance of HPV-related cancer. It is used to monitor head & neck cancer recurrence.
Information is owner-confirmed
Last updated 4 months ago
Price range